J M González-Clemente
Research Subjects
Research Interests
J M González-Clemente has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
- Didac Mauricio
CIBER de Diabetes y Enfermedades Metabólicas Asociadas, Instituto de Salud Carlos III, Barcelona, Spain
6 shared publications - Gabriel Giménez-Pérez
Hospital general de Granollers
5 shared publications - Ana Megia
Universitat Rovira i Virgili
3 shared publications - Assumpta Caixàs
Endocrinology and Nutrition Department, Parc Taulí Hospital Universitari, Parc Taulí 1, 08208, Sabadell, Spain
3 shared publications - Cristóbal Richart
Affiliation Department of Medicine and Surgery, Rovira i Virgili University, Tarragona, Spain
3 shared publications - Joan Vendrell
Institut de Recerca Biomèdica Catalunya Sud (formerly Institut d’Investigació Sanitària Pere Virgili), Hospital Universitari Joan XXIII, Tarragona 43005, Spain
3 shared publications
Latest Publications
- Open Access
- 1 July 2007
- Published by Oxford University Press (OUP) in European Journal of Endocrinology
- Vol. 157 (1) , 31-38
Lower heart rate variability is associated with higher plasma concentrations of IL-6 in type 1 diabetes
Objective: In type 1 diabetes, cardiovascular autonomic neuropathy (CAN) is associated with cardiovascular risk factors related to insulin resistance, which in turn are associated with low-grade systemic inflammation. Reduced heart rate variability (HRV) is considered one of the first indicators of CAN. Since the autonomic nervous system interacts with systemic inflammation, we evaluated CAN to study its possible association with low-grade systemic inflammation. Design: Cross-sectional study of a group of 120 subjects diagnosed with type 1 diabetes mellitus 14 years before. Methods: Information recorded: 1) clinical characteristics: sex, age, body mass index, waist-to-hip ratio (WHR), blood pressure (BP), smoking, alcohol intake, insulin dose, HbA1c, and lipid profile; 2) plasma levels of soluble fractions of tumour necrosis factor α receptors 1 and 2, IL-6, and C-reactive protein; 3) insulin resistance by estimation of the glucose disposal rate (eGDR); and 4) tests for CAN: HRV in response to deep breathing (E/I ratio), HRV in response to the Valsalva maneuver, and changes in systolic BP responding to standing. Results: A significant negative correlation was found between E/I ratio and plasma concentrations of IL-6 (r=−0.244, P=0.032), which remained significant after adjusting for potential confounding factors (age, sex, HbA1c, WHR, diastolic BP, triglycerides, HDL-cholesterol, retinopathy, nephropathy, peripheral neuropathy, insulin dose, and smoking; r=−0.231, P=0.039). No other significant associations were found between inflammation-related proteins, tests for CAN, and eGDR. Conclusions: These findings suggest a link between low-grade inflammation and early alterations of CAN in type 1 diabetes and may be of importance in the pathogenesis of CAN and/or its clinical implications.
- 1 July 2007
- Published by Oxford University Press (OUP) in European Journal of Endocrinology
- Vol. 157 (1) , 31-38
Open AccessLower heart rate variability is associated with higher plasma concentrations of IL-6 in type 1 diabetes
Objective: In type 1 diabetes, cardiovascular autonomic neuropathy (CAN) is associated with cardiovascular risk factors related to insulin resistance, which in turn are associated with low-grade systemic inflammation. Reduced heart rate variability (HRV) is considered one of the first indicators of CAN. Since the autonomic nervous system interacts with systemic inflammation, we evaluated CAN to study its possible association with low-grade systemic inflammation. Design: Cross-sectional study of a group of 120 subjects diagnosed with type 1 diabetes mellitus 14 years before. Methods: Information recorded: 1) clinical characteristics: sex, age, body mass index, waist-to-hip ratio (WHR), blood pressure (BP), smoking, alcohol intake, insulin dose, HbA1c, and lipid profile; 2) plasma levels of soluble fractions of tumour necrosis factor α receptors 1 and 2, IL-6, and C-reactive protein; 3) insulin resistance by estimation of the glucose disposal rate (eGDR); and 4) tests for CAN: HRV in response to deep breathing (E/I ratio), HRV in response to the Valsalva maneuver, and changes in systolic BP responding to standing. Results: A significant negative correlation was found between E/I ratio and plasma concentrations of IL-6 (r=−0.244, P=0.032), which remained significant after adjusting for potential confounding factors (age, sex, HbA1c, WHR, diastolic BP, triglycerides, HDL-cholesterol, retinopathy, nephropathy, peripheral neuropathy, insulin dose, and smoking; r=−0.231, P=0.039). No other significant associations were found between inflammation-related proteins, tests for CAN, and eGDR. Conclusions: These findings suggest a link between low-grade inflammation and early alterations of CAN in type 1 diabetes and may be of importance in the pathogenesis of CAN and/or its clinical implications.
- 1 February 2007
- Published by Elsevier in Diabetes & Metabolism
- Vol. 33 (1) , 25-29
Increased cholesterol intake in women with gestational diabetes mellitus
- 1 February 2007
- Published by Elsevier in Diabetes & Metabolism
- Vol. 33 (1) , 25-29
Increased cholesterol intake in women with gestational diabetes mellitus
- Open Access
- 1 November 2005
- Published by Oxford University Press (OUP) in European Journal of Endocrinology
- Vol. 153 (5) , 687-691
The tumour necrosis factor (TNF)-α system is activated in accordance with pulse pressure in normotensive subjects with type 1 diabetes mellitus
Objective: Pulse pressure (PP) and inflammation are important predictors of cardiovascular disease (CVD), even in the normotensive. The age-related increase in PP can be diagnosed up to 20 years earlier in subjects with type 1 diabetes mellitus (T1DM) than in the general population. Some evidence suggests that PP can stimulate inflammation. Our aim was to study the relationship between PP and plasma inflammatory proteins in normotensive subjects with T1DM. Design: This was a cross-sectional study of a group of normotensive (Methods: The following information was recorded: sex, age, body-mass index (BMI), waist-to-hip ratio (WHR), systolic blood pressure (SBP), diastolic blood pressure (DBP), PP, mean blood pressure (MBP), smoking, alcohol intake, insulin dose, lipid profile, HbA1c, microvascular complications, and plasma concentrations of soluble receptor types 1 and 2 of tumour necrosis factor (TNF)-α (sTNFR1 and sTNFR2, respectively), interleukin-6, C-reactive protein, adiponectin and leptin. Results: A total of 112 subjects were evaluated (aged 27.4±6.6 years, 52.7% women, BMI: 20.4±2.7 kg/m2, WHR: 0.82±0.09, SBP: 112±12 mmHg, DBP: 68±9 mmHg, PP: 45±9 mmHg, MBP: 82±9 mmHg, HbA1c: 8.2% (7.3–9.0%), 41.1% microvascular complications). After adjusting for potential confounders, only inflammatory markers of the TNF-α system correlated significantly with PP (Pearson correlation coefficient between sTNFR1 and PP: r = 0.215, P = 0.030; and between PP and sTNFR2: r = 0.238, P = 0.020). Conclusion: In normotensive subjects with T1DM after 14 years of diagnosis, the activation of the TNF-α system is positively associated with PP levels. This finding might suggest a pathogenic role of the TNF-α system in the development of cardiovascular disease in T1DM. Abstract Objective: Pulse pressure (PP) and inflammation are important predictors of cardiovascular disease (CVD), even in the normotensive. The age-related increase in PP can be diagnosed up to 20 years earlier in subjects with type 1 diabetes mellitus (T1DM) than in the general population. Some evidence suggests that PP can stimulate inflammation. Our aim was to study the relationship between PP and plasma inflammatory proteins in normotensive subjects with T1DM. Design: This was a cross-sectional study of a group of normotensive (Methods: The following information was recorded: sex, age, body-mass index (BMI), waist-to-hip ratio (WHR), systolic blood pressure (SBP), diastolic blood pressure (DBP), PP, mean blood pressure (MBP), smoking, alcohol intake, insulin dose, lipid profile, HbA1c, microvascular complications, and plasma concentrations of soluble receptor types 1 and 2 of tumour necrosis factor (TNF)-α (sTNFR1 and sTNFR2, respectively), interleukin-6, C-reactive protein, adiponectin and leptin. Results: A total of 112 subjects were evaluated (aged 27.4±6.6 years, 52.7% women, BMI: 20.4±2.7 kg/m2, WHR: 0.82±0.09, SBP: 112±12 mmHg, DBP: 68±9 mmHg, PP: 45±9 mmHg, MBP: 82±9 mmHg, HbA1c: 8.2% (7.3–9.0%), 41.1% microvascular complications). After adjusting for potential confounders, only inflammatory markers of the TNF-α system correlated significantly with PP (Pearson correlation coefficient between sTNFR1 and PP: r = 0.215, P = 0.030; and between PP and sTNFR2: r = 0.238, P = 0.020). Conclusion: In normotensive subjects with T1DM after 14 years of diagnosis, the activation of the TNF-α system is positively associated with PP levels. This finding might suggest a pathogenic role of the TNF-α system in the development of cardiovascular disease in T1DM.
- 1 November 2005
- Published by Oxford University Press (OUP) in European Journal of Endocrinology
- Vol. 153 (5) , 687-691
Open AccessThe tumour necrosis factor (TNF)-α system is activated in accordance with pulse pressure in normotensive subjects with type 1 diabetes mellitus
Objective: Pulse pressure (PP) and inflammation are important predictors of cardiovascular disease (CVD), even in the normotensive. The age-related increase in PP can be diagnosed up to 20 years earlier in subjects with type 1 diabetes mellitus (T1DM) than in the general population. Some evidence suggests that PP can stimulate inflammation. Our aim was to study the relationship between PP and plasma inflammatory proteins in normotensive subjects with T1DM. Design: This was a cross-sectional study of a group of normotensive (Methods: The following information was recorded: sex, age, body-mass index (BMI), waist-to-hip ratio (WHR), systolic blood pressure (SBP), diastolic blood pressure (DBP), PP, mean blood pressure (MBP), smoking, alcohol intake, insulin dose, lipid profile, HbA1c, microvascular complications, and plasma concentrations of soluble receptor types 1 and 2 of tumour necrosis factor (TNF)-α (sTNFR1 and sTNFR2, respectively), interleukin-6, C-reactive protein, adiponectin and leptin. Results: A total of 112 subjects were evaluated (aged 27.4±6.6 years, 52.7% women, BMI: 20.4±2.7 kg/m2, WHR: 0.82±0.09, SBP: 112±12 mmHg, DBP: 68±9 mmHg, PP: 45±9 mmHg, MBP: 82±9 mmHg, HbA1c: 8.2% (7.3–9.0%), 41.1% microvascular complications). After adjusting for potential confounders, only inflammatory markers of the TNF-α system correlated significantly with PP (Pearson correlation coefficient between sTNFR1 and PP: r = 0.215, P = 0.030; and between PP and sTNFR2: r = 0.238, P = 0.020). Conclusion: In normotensive subjects with T1DM after 14 years of diagnosis, the activation of the TNF-α system is positively associated with PP levels. This finding might suggest a pathogenic role of the TNF-α system in the development of cardiovascular disease in T1DM. Abstract Objective: Pulse pressure (PP) and inflammation are important predictors of cardiovascular disease (CVD), even in the normotensive. The age-related increase in PP can be diagnosed up to 20 years earlier in subjects with type 1 diabetes mellitus (T1DM) than in the general population. Some evidence suggests that PP can stimulate inflammation. Our aim was to study the relationship between PP and plasma inflammatory proteins in normotensive subjects with T1DM. Design: This was a cross-sectional study of a group of normotensive (Methods: The following information was recorded: sex, age, body-mass index (BMI), waist-to-hip ratio (WHR), systolic blood pressure (SBP), diastolic blood pressure (DBP), PP, mean blood pressure (MBP), smoking, alcohol intake, insulin dose, lipid profile, HbA1c, microvascular complications, and plasma concentrations of soluble receptor types 1 and 2 of tumour necrosis factor (TNF)-α (sTNFR1 and sTNFR2, respectively), interleukin-6, C-reactive protein, adiponectin and leptin. Results: A total of 112 subjects were evaluated (aged 27.4±6.6 years, 52.7% women, BMI: 20.4±2.7 kg/m2, WHR: 0.82±0.09, SBP: 112±12 mmHg, DBP: 68±9 mmHg, PP: 45±9 mmHg, MBP: 82±9 mmHg, HbA1c: 8.2% (7.3–9.0%), 41.1% microvascular complications). After adjusting for potential confounders, only inflammatory markers of the TNF-α system correlated significantly with PP (Pearson correlation coefficient between sTNFR1 and PP: r = 0.215, P = 0.030; and between PP and sTNFR2: r = 0.238, P = 0.020). Conclusion: In normotensive subjects with T1DM after 14 years of diagnosis, the activation of the TNF-α system is positively associated with PP levels. This finding might suggest a pathogenic role of the TNF-α system in the development of cardiovascular disease in T1DM.
- 27 September 2005
- Published by Wiley in Clinical Endocrinology
- Vol. 63 (5) , 525-529
Diabetic neuropathy is associated with activation of the TNF‐α system in subjects with type 1 diabetes mellitus
Summary: Objective The development of diabetic neuropathy (DN) is predicted by cardiovascular risk factors associated with insulin resistance. As inflammation seems to be implicated in the pathogenesis of insulin resistance, we investigated whether subjects with type 1 diabetes mellitus (T1DM) and DN have an increase in plasma concentrations of inflammatory proteins involved in insulin resistance.Design Cross‐sectional.Patients One hundred twenty subjects, all diagnosed with T1DM 14 years before.Measurements (1) Sex, age, body mass index, waist‐to‐hip ratio (WHR), blood pressure, smoking, alcohol intake, insulin dose, HbA1c and lipid profile; (2) DN (peripheral and cardiac autonomic), retinopathy and nephropathy; (3) plasma concentrations of soluble fractions of tumour necrosis factor α receptors 1 and 2 (sTNFR1 and sTNFR2), interleukin‐6, high‐sensitive C‐reactive protein, adiponectin and leptin; and (4) insulin resistance (by way of a mathematical estimation of the glucose disposal rate – eGDR‐).Results Thirty‐six subjects had DN and 84 did not. Subjects with DN received higher insulin doses (57·6 ± 16·7 vs. 49·2 ± 15·0 IU/day; P = 0·008) and had higher WHR (0·85 ± 0·07 vs. 0·81 ± 0·10; P = 0·007) and HbA1c values (8·5 (7·6–9·6) vs. 7·7 (7·3–8·9)%; P = 0·049) than subjects without DN. They also had higher values of sTNFR1 (2·42 ± 0·60 vs. 1·96 ± 0·66 µg/l; P = 0·001) and sTNFR2 (4·73 ± 1·33 vs. 4·14 ± 1·09 µg/l; P = 0·015), and were more insulin resistant (eGDR values: 7·28 (5·83–8·03) vs. 8·30 (7·17–9·03) mg kg−1 min−1; P = 0·003). The relationship between DN and either sTNFR1 or sTNFR2 remained essentially unchanged after adjusting for several confounders, including glycaemic control, WHR, lipid profile, blood pressure and other microvascular complications (OR for sTNFR1: 2·592 (1·222–5·498), P = 0·013; OR for sTNFR2: 2·124 (1·258–3·587), P = 0·005).Conclusions The activity of the TNF‐α system is increased in subjects with type 1 diabetes mellitus and diabetic neuropathy, regardless of their glycaemic control and cardiovascular risk factors associated with insulin resistance. These results suggest that TNF‐α may play a pathogenic role in the development of diabetic neuropathy.
- 27 September 2005
- Published by Wiley in Clinical Endocrinology
- Vol. 63 (5) , 525-529
Diabetic neuropathy is associated with activation of the TNF‐α system in subjects with type 1 diabetes mellitus
Summary: Objective The development of diabetic neuropathy (DN) is predicted by cardiovascular risk factors associated with insulin resistance. As inflammation seems to be implicated in the pathogenesis of insulin resistance, we investigated whether subjects with type 1 diabetes mellitus (T1DM) and DN have an increase in plasma concentrations of inflammatory proteins involved in insulin resistance.Design Cross‐sectional.Patients One hundred twenty subjects, all diagnosed with T1DM 14 years before.Measurements (1) Sex, age, body mass index, waist‐to‐hip ratio (WHR), blood pressure, smoking, alcohol intake, insulin dose, HbA1c and lipid profile; (2) DN (peripheral and cardiac autonomic), retinopathy and nephropathy; (3) plasma concentrations of soluble fractions of tumour necrosis factor α receptors 1 and 2 (sTNFR1 and sTNFR2), interleukin‐6, high‐sensitive C‐reactive protein, adiponectin and leptin; and (4) insulin resistance (by way of a mathematical estimation of the glucose disposal rate – eGDR‐).Results Thirty‐six subjects had DN and 84 did not. Subjects with DN received higher insulin doses (57·6 ± 16·7 vs. 49·2 ± 15·0 IU/day; P = 0·008) and had higher WHR (0·85 ± 0·07 vs. 0·81 ± 0·10; P = 0·007) and HbA1c values (8·5 (7·6–9·6) vs. 7·7 (7·3–8·9)%; P = 0·049) than subjects without DN. They also had higher values of sTNFR1 (2·42 ± 0·60 vs. 1·96 ± 0·66 µg/l; P = 0·001) and sTNFR2 (4·73 ± 1·33 vs. 4·14 ± 1·09 µg/l; P = 0·015), and were more insulin resistant (eGDR values: 7·28 (5·83–8·03) vs. 8·30 (7·17–9·03) mg kg−1 min−1; P = 0·003). The relationship between DN and either sTNFR1 or sTNFR2 remained essentially unchanged after adjusting for several confounders, including glycaemic control, WHR, lipid profile, blood pressure and other microvascular complications (OR for sTNFR1: 2·592 (1·222–5·498), P = 0·013; OR for sTNFR2: 2·124 (1·258–3·587), P = 0·005).Conclusions The activity of the TNF‐α system is increased in subjects with type 1 diabetes mellitus and diabetic neuropathy, regardless of their glycaemic control and cardiovascular risk factors associated with insulin resistance. These results suggest that TNF‐α may play a pathogenic role in the development of diabetic neuropathy.
- 1 November 2003
- Published by Elsevier in Diabetes Research and Clinical Practice
- Vol. 62 (2) , 123-129
Translation of the recommendations for the diagnosis of diabetes mellitus into daily clinical practice in a primary health care setting.
- 1 November 2003
- Published by Elsevier in Diabetes Research and Clinical Practice
- Vol. 62 (2) , 123-129
Translation of the recommendations for the diagnosis of diabetes mellitus into daily clinical practice in a primary health care setting.
- 1 January 2003
- Published by Elsevier in Revista Clínica Española
- Vol. 203 (10) , 465-471
Evaluación del proceso y los resultados de la atención a los pacientes diabéticos en un hospital
- 1 January 2003
- Published by Elsevier in Revista Clínica Española
- Vol. 203 (10) , 465-471
Evaluación del proceso y los resultados de la atención a los pacientes diabéticos en un hospital
- 20 November 1999
- Vol. 113 (17) , 641-5
[Hypovitaminosis D: its high prevalence in elderly outpatients in Barcelona. Associated factors].
Hypovitaminosis D is a frequent finding in the elderly of northern countries. In Spain because of high sun irradiation it has been traditionally considered that hypovitaminosis D is not a frequent problem. In this study we have evaluated the prevalence of hypovitaminosis D in the elderly and the associated factors. All individuals older than 65 years attending a primary care unit (november 1995-march 1996) and without any disease modifying vitamin D status were included. The following data were recorded: age, gender, height, weight, white and red cell counts, glycaemia, serum ions, albuminemia, plasma creatinine, creatinine clearance, urinary creatinine and calcium, parathyroid hormone (PTHi), calcidiol and calcitriol. Sun exposure and fish ingestion was also determined by questionnaire. 127 individuals were evaluated (age: mean [SD] 74.8 [6.4] years; 47 men, 37.0%). Forty-four subjects (34.6%; CI 95%: 26.3-42.9%) had calcidiol levels < or = 10 ng/ml, 15 (11.8%; CI 95%: 6.2-17.4%) low values of calcidiol, and 13 (10.2%; CI 95%: 4.9-15.5%) high PTHi values. Subjects with hypovitaminosis D (calcidiol levels < or = 10 ng/ml) were mainly women, older, short stature, had a lower values of body surface, albuminemia, phosphatemia, creatinine clearance, sun exposure and fish intake and higher PTHi levels. In the logistic regression model, hypovitaminosis D was positively associated with age and negatively with sun exposure, albuminemia, height and phosphoremia. Hypovitaminosis D is a very frequent finding in Spanish elderly people. Its presence is independently associated with age (positively) and sun exposure, serum albumin, height and phosphoremia (negatively).
- 20 November 1999
- Vol. 113 (17) , 641-5
[Hypovitaminosis D: its high prevalence in elderly outpatients in Barcelona. Associated factors].
Hypovitaminosis D is a frequent finding in the elderly of northern countries. In Spain because of high sun irradiation it has been traditionally considered that hypovitaminosis D is not a frequent problem. In this study we have evaluated the prevalence of hypovitaminosis D in the elderly and the associated factors. All individuals older than 65 years attending a primary care unit (november 1995-march 1996) and without any disease modifying vitamin D status were included. The following data were recorded: age, gender, height, weight, white and red cell counts, glycaemia, serum ions, albuminemia, plasma creatinine, creatinine clearance, urinary creatinine and calcium, parathyroid hormone (PTHi), calcidiol and calcitriol. Sun exposure and fish ingestion was also determined by questionnaire. 127 individuals were evaluated (age: mean [SD] 74.8 [6.4] years; 47 men, 37.0%). Forty-four subjects (34.6%; CI 95%: 26.3-42.9%) had calcidiol levels < or = 10 ng/ml, 15 (11.8%; CI 95%: 6.2-17.4%) low values of calcidiol, and 13 (10.2%; CI 95%: 4.9-15.5%) high PTHi values. Subjects with hypovitaminosis D (calcidiol levels < or = 10 ng/ml) were mainly women, older, short stature, had a lower values of body surface, albuminemia, phosphatemia, creatinine clearance, sun exposure and fish intake and higher PTHi levels. In the logistic regression model, hypovitaminosis D was positively associated with age and negatively with sun exposure, albuminemia, height and phosphoremia. Hypovitaminosis D is a very frequent finding in Spanish elderly people. Its presence is independently associated with age (positively) and sun exposure, serum albumin, height and phosphoremia (negatively).